The study sought to assess the rate of recurrent stroke and death in stroke patients with a
patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter
study conducted at 48 U.S. Institutions.
Phase:
Phase 4
Details
Lead Sponsor:
Columbia University
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)